Читать книгу Clinical Pharmacology and Therapeutics - Группа авторов - Страница 114

A chemist in a major pharmaceutical company has been performing research into a compound that appears to provide neuronal protection from ischaemia in in vitro models. This discovery has caused some excitement – if it is shown to have efficacy in humans then it might be a useful treatment for patients with acute stroke. What are the various stages that this compound has to go through in development before it can be licenced as a drug to be used in patients?